Form 4: Herbalife Executive Troy Hicks Reports Stock Transactions
SEC Form 4
Troy Hicks, Chief Operating Officer of Herbalife Ltd., reports the acquisition and disposal of company stock and stock appreciation rights.
Summary
- Troy Hicks, the Chief Operating Officer of Herbalife Ltd., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
- On February 25, 2025, 1,548 shares of common stock were disposed of at a price of $8.29 to cover tax obligations related to vesting restricted stock units.
- Hicks also reported the acquisition of 52,445 stock appreciation rights (SARs) on February 21, 2025, with an exercise price of $8.31.
- These SARs will vest in one-third increments on February 21, 2026, February 21, 2027, and February 21, 2028, contingent upon continued service.
- The balance of common stock beneficially owned following the reported transactions is 56,447 shares, which includes shares purchased through the Employee Stock Purchase Plan since June 10, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects standard executive compensation practices and tax obligation fulfillment. The acquisition of SARs is a mildly positive signal.
Positives
- The acquisition of stock appreciation rights suggests a belief in the future performance of Herbalife.
- Continued participation in the Employee Stock Purchase Plan indicates ongoing investment in the company.
Future Outlook
The stock appreciation rights vest in three annual installments starting February 21, 2026, contingent on continued service.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to track management's sentiment and actions regarding their company's stock.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- The vesting schedule of the stock appreciation rights (one-third annually over three years) is a common practice in executive compensation plans.
- Companies like Nu Skin Enterprises and USANA Health Sciences, which operate in the same industry as Herbalife, also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- The transactions provide transparency to shareholders regarding executive compensation and stock ownership.
- The vesting schedule of the stock appreciation rights incentivizes the executive to remain with the company and contribute to its long-term success.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of Reporting Person's last Form 3 filing |
| 02/21/2025 | Date of earliest transaction and grant date of stock appreciation rights |
| 02/25/2025 | Date of stock disposal for tax obligations |
| 02/21/2026 | First vesting date of stock appreciation rights (one-third) |
| 02/21/2027 | Second vesting date of stock appreciation rights (one-third) |
| 02/21/2028 | Third vesting date of stock appreciation rights (one-third) |
| 02/21/2035 | Expiration date of stock appreciation rights |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.